Latest News and Press Releases

Arcutis today announced that it will report its Q1 2026 financial results and provide a business update on May 6, 2026 after the U.S. markets close.

Arcutis today announced that Arcutis management will present at the 25th Annual Needham Virtual Healthcare Conference, taking place April 13-16, 2026.

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at 2026 AAD

Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at AAD 2026

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data in Pediatric Dermatology

Arcutis Announces Promotion of Mas Matsuda to Executive Vice President and Chief Legal Officer to Support Next Phase of Growth

Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis

Arcutis today announced that management will participate in the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston.

Arcutis today reported financial results for the quarter and year ended December 31, 2025, and provided a business update.

Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seb Derm to Speak with Their Healthcare Provider